Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Orthobiologics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Orthobiologics Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Orthobiologics Market, by Application, 2019-2029 (USD Billion)
1.2.4. Orthobiologics Market, by End-user, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Orthobiologics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Orthobiologics Market Dynamics
3.1. Orthobiologics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising cases of Orthopedic Injuries
3.1.1.2. Increasing aging population
3.1.2. Market Challenges
3.1.2.1. High Cost of Orthobiologics
3.1.3. Market Opportunities
3.1.3.1. Improvement in healthcare infrastructure
Chapter 4. Global Orthobiologics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Orthobiologics Market, by Product Type
6.1. Market Snapshot
6.2. Global Orthobiologics Market by Product Type, Performance - Potential Analysis
6.3. Global Orthobiologics Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Orthobiologics Market, Sub Segment Analysis
6.4.1. Viscosupplements
6.4.2. Bone Growth Factors
6.4.3. Demineralized Bone Matrix (DBM)
6.4.4. Synthetic Bone Substitutes
6.4.5. Cellular Allograft
6.4.6. Allografts
6.4.7. Others
Chapter 7. Global Orthobiologics Market, by Application
7.1. Market Snapshot
7.2. Global Orthobiologics Market by Application, Performance - Potential Analysis
7.3. Global Orthobiologics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Orthobiologics Market, Sub Segment Analysis
7.4.1. Spinal Fusion
7.4.2. Maxillofacial & Dental
7.4.3. Soft Tissue Repair
7.4.4. Reconstructive & Fracture Surgery
7.4.5. Others
Chapter 8. Global Orthobiologics Market, by End-user
8.1. Market Snapshot
8.2. Global Orthobiologics Market by End-user, Performance - Potential Analysis
8.3. Global Orthobiologics Market Estimates & Forecasts by End-user 2019-2029 (USD Billion)
8.4. Orthobiologics Market, Sub Segment Analysis
8.4.1. Hospitals & Ambulatory Surgical Centers (ASCs)
8.4.2. Specialty Clinics
8.4.3. Others
Chapter 9. Global Orthobiologics Market, Regional Analysis
9.1. Orthobiologics Market, Regional Market Snapshot
9.2. North America Orthobiologics Market
9.2.1. U.S. Orthobiologics Market
9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Orthobiologics Market
9.3. Europe Orthobiologics Market Snapshot
9.3.1. U.K. Orthobiologics Market
9.3.2. Germany Orthobiologics Market
9.3.3. France Orthobiologics Market
9.3.4. Spain Orthobiologics Market
9.3.5. Italy Orthobiologics Market
9.3.6. Rest of Europe Orthobiologics Market
9.4. Asia-Pacific Orthobiologics Market Snapshot
9.4.1. China Orthobiologics Market
9.4.2. India Orthobiologics Market
9.4.3. Japan Orthobiologics Market
9.4.4. Australia Orthobiologics Market
9.4.5. South Korea Orthobiologics Market
9.4.6. Rest of Asia Pacific Orthobiologics Market
9.5. Latin America Orthobiologics Market Snapshot
9.5.1. Brazil Orthobiologics Market
9.5.2. Mexico Orthobiologics Market
9.5.3. Rest of Latin America Orthobiologics Market
9.6. Rest of The World Orthobiologics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Medtronic (Ireland)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Zimmer Biomet (U.S.)
10.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.) (U.S.)
10.2.4. Stryker (U.S.)
10.2.5. Anika Therapeutics, Inc. (U.S.)
10.2.6. SeaSpine (U.S.)
10.2.7. Bioventus (U.S.)
10.2.8. RTI Surgical (U.S.)
10.2.9. MTF Biologics (U.S.)
10.2.10. Arthrex, Inc. (U.S.)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption